Arboviruses: Togaviridae & Flaviviridae Flashcards

1
Q

Arboviruses

A

arthropod borne viruses
viruses are biologically transmitted between susceptible vertebrate hosts by blood feeding arthropods (insects, ticks) or through transovarian or venerial transmission in arthropods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vector

A

an organism that transmits a disease agent from one animal or plant to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Arbovirus Transmission Cycle

A

virus arthropod vector host virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mosquito borne virus transmission cycle

A
mosquito  host (bird) --> host (horse)
intrinsic incubation period
extrinsic incubation period
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

intrinsic incubation period

A

time taken by an organism to complete its development in the definitive host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

extrinsic incubation period

A

interval between the acquisition of an infectious agent by a vector and the vectors to other susceptible vertebrates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

West Nile Virus Transmission Cycle

A

mosquito (vector) bird reservoir host –> human & horse (incidental infection)

enzootic cycle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Types of Arbovirus Transmission by Mosquitos

A

Horizontal Transmission:

  • vector to vertebrate
  • vector to vector (venereal)

Vertical Transmission (parent passes virus to offspring)

  • transovarial (ovarian follicles are permissive to virus replication)
  • transovum (virus transferred to egg as the egg passes through oviduct)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Family: Togaviridae

A
  • genome: linear, ssRNA (+)
  • icosahedral capsid
  • surrounded by an envelope “toga” (lipids derived from host cell membrane; glycoprotein spikes protruding from surface of virion= unique antigenic determinants for alpha viruses)
  • spherical
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Genera of Togaviridae

A
Alphavirus:
Sindbis 
Eastern equine encephalitis
Western equine encephalitis
Venezuelan equine encephalitis
Ross River
O’nyong’nyong 
Semliki Forest
Chikungunya

Rubivirus:
Rubella virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alphavirus

A

genera of togaviridae
vector= mosquitos
vertebrate reservoir hosts= wild birds, rodents, wild primates, humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Arbovirus nomenclature

A

may be based on endemic areas and symptoms induced by virus infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alphavirus & Rubivirus- Structure & Replication

A

Genome encodes early (non-structural) and late (structural) proteins

Replication is in the cytoplasm
Viruses bud at the plasma membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alphavirus & Rubivirus- Attachment & Replication

A

Virus entry into cells by receptor-mediated endocytosis
(each virus has a different host range depending on glycoprotein affinity to host cell receptors)

Viral envelope then fuses with the membrane of the endosome upon acidification of the vesicle to release the capsid and genome into the cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alphavirus & Rubivirus- Synthesis of Early Proteins

A

In cytoplasm, viral RNA binds to the ribosome as the messenger RNA

Initially, the genome is translated (2/3rds of genome) into a polyprotein which is cleaved by proteases into four nonstructural early proteins (NSP 1-4)

These proteins include a protease activity and an RNA-dependent RNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Alphavirus & Rubivirus- Synthesis of Late Proteins

A

A full-length (-) sense RNA (42S) is transcribed by RNA polymerase which acts as a template for more viral genome
–Many positive (+) RNA strands formed from the template

A smaller (26S) RNA is transcribed from this template

  • -This RNA encodes the capsid and envelope proteins
  • -Capsid proteins formed by protease cleavage of the polyprotein produced from the 26S RNA (translated 1st and cleaved)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Alphavirus & Rubivirus- Assembly

A

Capsid proteins associate with genomic RNA after synthesized and bind them to areas of the cell membrane which express the viral glycoproteins (E1, E2, E3)

Glycoproteins associate with the capsid

Viruses released from host cell via budding

18
Q

Alphavirus & Rubivirus Replication Cycle

A

1-receptor mediated endocytosis

2-endosome acidification

3-translation of RNA genome (i.e., protein synthesis)

4-proteolytic cleavage

5-replication of genome - + -

6-subgenome

7-protein synthesis membrane insertion

8-assembly

9-budding

19
Q

Clinical Syndromes of Alphaviruses

A

Usually low grade and mild (fever, chills, rash, aches)

Flu-like symptoms coincide with systemic infection during the initial viremia (3 to 10 days)
(replication in the reticuloendothelial system–component of immune system)

May progress to encephalitis (inflammation of the brain) in humans but usually resolve without sequelae (after effect of disease)

20
Q

Alphavirus: “Encephalitis Illness”

A

Eastern equine encephalitis virus=

  • Culiseta melanura, Culex spp., Aedes spp. (mosquitos)
  • Amplification hosts: wild birds
  • 5% of infections result in encephalitis (33% mortality and brain damage in most survivors)

Venezuelan equine encephalitis virus=

  • Culex spp. (mosquitos)
  • Amplification hosts: rodents
  • emerging pathogen of humans/equines in neotropics (outbreaks may involve thousands of equine/human cases, spread over large regions, lasting several years)

Western equine encephalitis virus=

  • Culex spp. (mosquitos)
  • Amplification hosts: wild birds
  • 639 confirmed cases in U.S. since 1964

incidental infection: humans & horses

21
Q

Alphavirus: “Febrile Illness”

A

O’nyong-nyong virus (ONYV)=
-Means “weakening of the joints”
-Anopheles spp. (mosquito)
-Hosts: humans
-Fever, rash, polyarthritis, eye pain, chest pain,
inflammation of lymph nodes, lethargy (no mortality)

Chikungunya virus (CHIKV)=
-Means “that which bends up”
-Aedes spp. (mosquito)
- Active during day and anthropophilic
-Hosts: humans (reservoir host)
- Urban transmission cycle
    (Human-mosquito-human transmission)
-Fever (2-5 d), joint pains (weeks to months), rash, headache, muscle pain, nausea, fatigue

–> A single mutation (E1-A226V) in CHIKV resulted in increased fitness of CHIKV in A. albopictus mosquitoes with respect to:
midgut infectivity
dissemination to the salivary glands
transmission to vertebrate hosts

22
Q

Rubivirus

A

genera of togaviridae
Not transmitted by insect vectors (contagious)

Shares the structural properties and mode of replication as other togaviruses

Rubella is transmitted by airborne droplets (coughing/sneezing)

Rarely causes serious illness in infants and young children, but infection in pregnant women can cause unborn babies to have serious congenital defects or death

Children infected with rubella virus may have;
Incubation period, 14-21 days
rash (starts on face and spreads to neck, chest, arms, legs) lasting ≈3 days
swelling of lymph nodes
fever

Adult infection (may be more severe, arthralgia)

23
Q

Rubella infection during pregnancy

A

may lead to miscarriage, stillbirth, premature delivery, and birth defects

Risk is highest during initial 12 weeks of pregnancy

Birth defects include deafness, cataracts, heart defects, mental retardation (called Congenital Rubella Syndrome, CRS)

24
Q

Congenital Rubella Syndrome (CRS)

A

deafness, cataracts, heart defects, mental retardation

25
Rubella Vaccine
Single vaccine dose gives >95% long-lasting immunity 1969- U.S. was 1st country to begin to use rubella vaccine (2004 rubella considered “eliminated” in U.S.) WHO program (Eliminating measles & rubella & preventing congenital rubella infection) CRS highest in African/South East Asian regions where vaccine coverage is lowest
26
Family: Flaviviridae
``` Four genera: Flavivirus (> 70 viruses) - Yellow fever - West Nile encephalitis - Dengue - Japanese encephalitis - St. Louis encephalitis - Russian Spring-Summer encephalitis - Powassan encephalitis ``` Hepacivirus - Hepatitis C - GB virus B Pegivirus - GB virus A - GB virus C Pestivirus - Bovine viral diarrhea virus - Classical swine fever
27
Flavivirus
``` genera of flaviviridae Enveloped icosahedral symmetry ssRNA (+) genome Transmitted mainly by mosquitoes and ticks ```
28
Flavivirus- Attachment & Replication
similar to alphaviruses: Virus entry into cells by receptor-mediated endocytosis (each virus has a different host range depending on glycoprotein affinity to host cell receptors) Viral envelope then fuses with the membrane of the endosome upon acidification of the vesicle to release the capsid and genome into the cytoplasm
29
Flaviviridae- Replication of genome, protein synthesis, & release
unlike alphaviruses: Entire genome translated into a single polyprotein structural genes at 5’ end of genome - Structural proteins are synthesized first, before catalytic proteins (may decrease efficiency of viral replication--latent periods before disease) Acquire envelope by budding into intracellular vesicles Released by exocytosis or cell lysis
30
Clinical Syndromes of Flaviviruses
Most infections are benign Serious encephalitis and hemorrhagic disease sometimes: - Yellow fever - Dengue hemorrhagic fever and dengue shock syndrome - West Nile - St. Louis Encephalitis - Japanese Encephalitis
31
Flavivirus: Encephalitis Illness
Japanese encephalitis virus= Culex tritaeniorhynchus Amplification hosts: pigs; Incidental hosts: humans, horses
32
Zika Virus- Transmission
Sylvatic transmission cycle Mosquitoes - Circulation occurring primarily between humans and A. aegypti, and to a lesser extent A. albopictus and A. hensillie From mother to child (rare) - A mother infected with ZIKV can pass virus to newborn around time of birth - ZIKV could be passed from mother to her fetus during pregnancy - No reports of infants being infected with ZIKV through breastfeeding Infected blood or sexual contact - Spread of ZIKV through blood transfusion and sexual contact have been reported
33
Spread of Zika
Emergence of ZIKV outside Africa coincided with switch of a sylvan cycle to cycle with humans and domestic mosquitoes
34
Flavivirus: Febrile/Hemorrhagic Illness
Yellow fever virus (YFV)= Aedes spp. Humans Amplification hosts: humans Rapid onset chills, headache, dizziness, myalgia then nausea, vomiting and bradycardia (slow heart rate) Progresses to jaundice, renal failure and systemic hemorrhage (15% of cases) (up to 50% mortality) Dengue virus (DENV)= Aedes spp. Humans Amplification hosts: humans Lasts 2-7 days Symptoms: malaise, headache, retro-orbital pain, myalgia, and arthralgia Manifests from mild to severe forms - Dengue fever, dengue hemorrhagic fever and dengue shock syndrome (may be associated with mortality) - Four serotypes of DENV (1-4) Primary vectors A. aegypti A. albopictus
35
Yellow fever transmission patterns
Jungle (sylvatic), intermediate, urban
36
Dengue Hemorrhagic Fever
Infection with one serotype provides long term protection against reinfection with the same serotype in the future Short-term cross protection among infection with heterospecific serotypes which then declines and then hypersensitivity reaction so that infection is more severe - internal bleeding - loss of plasma - shock
37
Model of antibody-dependent enhancement of dengue infection
Preexisting antibodies present in body from primary infection bind to infecting DENV during a subsequent infection with different dengue serotype Antibodies from the primary infection cannot neutralize the virus Instead, Ab-virus complex attaches to Fc receptors on circulating monocytes Antibodies help virus infect monocytes more efficiently Outcome is an increase in overall replication of virus and risk of severe disease
38
Upsurge of Dengue Hemorrhagic Fever
- Distribution (expanding distribution of multiple serotypes (co-circulating in same areas) & mosquito vectors) - Immune enhancement (Secondary type antibody response) - increased virus virulence (e.g., Asian dengue virus genotypes may outcompete American genotypes) - Breakdown of mosquito control in urban areas - Urbanization (uncontrolled) - Increased travel (Air travel)
39
Control of dengue and other mosquito-borne virus diseases
Vaccines: - EEE, WEE, Japanese, Russian encephalitis, VEE, YF - DENV (Dengvaxia® by Sanofi Pasteur) approved in Mexico, Philippines, and Brazil in December 2015 Reduce the abundance of mosquito vectors to control risk of disease transmission (still highly effective and main method)
40
Integrated Vector management
- Vector surveillance (larvae and adults) - Habitat modifications (e.g., source reduction, impoundments) - Chemical control (larvicide, adulticide) - Biological control (pathogens and predators) - Genetically modified insects (Release of insects carrying dominant lethals) and symbionts (Wolbachia) that kill/decrease ability to transmit pathogens Personal protection (vaccination, drugs, repellants, bednets, screens, protective clothing)